Direct regulation of TWIST by HIF-1α promotes metastasis
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Stabilization of the hypoxia-inducible factor-1alpha (HIF-1alpha) transcription complex, caused by intratumoural hypoxia, promotes tumour progression and metastasis, leading to treatment failure and mortality in different types of human cancers. The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis. Notably, HIF-1alpha- and TWIST-null mice show similarities in their phenotypes. Here, we have shown that hypoxia or overexpression of HIF-1alpha promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes. We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter. However, siRNA-mediated repression of TWIST in HIF-1alpha-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes. Co-expression of HIF-1alpha, TWIST and Snail in primary tumours of patients with head and neck cancers correlated with metastasis and the worst prognosis. These results provide evidence of a key signalling pathway involving HIF-1alpha and TWIST that promotes metastasis in response to intratumoural hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia and HIFs contribute to EMT by upregulating transcriptional repressors such as SNAIL (Imai et al., 2003), TWIST (Yang et al., 2008), TCF3, ZFHX1A, and ZFHX1B (Krishnamachary et al., 2006), whose gene products in turn repress CDH1.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Yang et al., 2008
In the citing paper
“Achieving vascular normalization, and thereby reducing tumour hypoxia and acidosis, is crucial because these stressors confer cancer cells with an invasive metastatic phenotype72”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [72]
In the citing paper
“Studies have demonstrated that HIF has a direct regulatory effect on EMT‐related proteins, such as zinc finger E‐box binding homeobox 1, Snail and Twist.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [85]
In the citing paper
“In experimental models, overexpression of HIF in tumor cells promotes metastasis”
From Hypoxic control of metastasis (2016) · cites this paper as [42]
In the citing paper
“Hypoxia or overexpression of HIF is sufficient to induce EMT and invasion in multiple cell types”
From Hypoxic control of metastasis (2016) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Intratumoural hypoxia, followed by stabilization and activation of the HIF-1α transcription complex, is one of the most important mechanisms that promotes metastasis and thereby, increases tumour aggressivenes”
BackgroundCancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247 · cited 1×
“dtd" [ ]> Tumour metastasis is the primary cause of death for most cancer patient”
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 1×
“EMT, one of the central mechanisms that induces invasion and metastasis of tumours, is a process by which epithelial cells lose their polarity and are converted to a mesenchymal phenotyp”
BackgroundTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855 · cited 1×
“Recently, TWIST was shown to be essential in mediating cancer metastasi”
BackgroundCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundCellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 1×
“Mutant phenotypes of HIF-1α - and TWIST -null mice show similarities, including defects in somites and abnormal formation of neural fold”
Background
Cited by
Items 601–700 of 1,000
The Clinical Significance of Vimentin-Expressing Gastric Cancer Cells in Bone Marrow
Iwatsuki, M., Mimori, K., Fukagawa, T., Ishii, H., Yokobori, T., Sasako, M., Baba, H. A., & Mori, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1041-0 · Cited by 46
“Circulating gastric cancer cells in circulating system can overcome the deadly circumstance by the acquisition of a dynamic morphologic change, named EMT.”
BackgroundInfluentialRedox regulation of cancer stem cells: Biology and therapeutic implications
Du, M., Zhang, J., Wicha, M. S., & Luo, M. (2024) · MedComm – Oncology · doi:10.1002/mog2.70005 · Cited by 57
Zhang, W., Yao, W., Yan, Q., Ma, F., Shi, X., Zhao, Y., Peng, Y., Wang, J., & Jiang, B. (2013) · Oncology Reports · doi:10.3892/or.2013.2828 · Cited by 45
Chen, S.-Y., Teng, S., Cheng, T.-H., & Wu, K.-J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.006 · Cited by 47
Self-citationMathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia
Dhawan, A., Tonekaboni, S. A. M., Taube, J. H., Hu, S. C., Sphyris, N., Mani, S. A., & Kohandel, M. (2016) · Scientific Reports · doi:10.1038/srep18074 · Cited by 48
Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression
Lin, Y., Shyu, W., Chang, C., Wang, C.-C., Wu, C., Lee, H., Chen, L., & Hsieh, C. (2017) · Theranostics · doi:10.7150/thno.17895 · Cited by 46
Migault, M., Sapkota, S., & Bracken, C. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04199-0 · Cited by 48
Overexpression and β-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1
Kim, Y.-S., Ahn, Y. H., Song, K. J., Kang, J. G., Lee, J. H., Jeon, S. K., Kim, H.-C., Yoo, J. S., & Ko, J.-H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370064 · Cited by 44
A Negative Feedback of the HIF-1α Pathway via Interferon-Stimulated Gene 15 and ISGylation
Yeh, Y.-H., Yang, Y. S. H., Hsieh, M., Yeh, Y.-C., & Li, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0018 · Cited by 49
“We performed luciferase reporter experiments using a Twist promoter construct (pTwist-Luc) containing hypoxia-responsive elements (HREs) (39).”
Teng, Y., & Xu, L. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9621-6 · Cited by 50
Kanamori, A., Matsubara, D., Saitoh, Y., Fukui, Y., Gotoh, N., Kaneko, S., Seiki, M., Murakami, Y., Inoue, J., & Sakamoto, T. (2020) · Oncogene · doi:10.1038/s41388-020-01423-8 · Cited by 47
Lv, N., Shan, Z., Gao, Y., Guan, H., Fan, C., Wang, H., & Teng, W. (2015) · Endocrine · doi:10.1007/s12020-015-0714-7 · Cited by 44
Gammon, L., & Mackenzie, I. C. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12327 · Cited by 47
miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells
Yeh, T.-C., Huang, T., Yeh, T.-S., Chen, Y.-R., Hsu, K., Yin, P., Lee, H., & Tseng, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168171 · Cited by 44
Jia, Z., Lian, W., Shi, H., Cao, C., Han, S., Wang, K., Li, M., & Zhang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-16366-6 · Cited by 49
Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers
Davoodvandi, A., Farshadi, M., Zare, N., Akhlagh, S. A., Nosrani, E. A., Mahjoubin‐Tehran, M., Kangari, P., Sharafi, S. M., Khan, H. Z., Aschner, M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.668567 · Cited by 50
Iguchi, N., Hou, A. H., Koul, H. K., & Wilcox, D. T. (2014) · The Journal of Urology · doi:10.1016/j.juro.2014.03.037 · Cited by 44
Yang, Y., Na, H. J., Suh, M. J., Ban, M., Byeon, H., Kim, W., Kim, J. W., Choi, E., Kwon, H., Chang, J., et al. (2015) · Yonsei medical journal · doi:10.3349/ymj.2015.56.6.1503 · Cited by 46
The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer
Gakis, G., Todenhöfer, T., & Stenzl, A. (2011) · Current Opinion in Urology · doi:10.1097/mou.0b013e32834966fa · Cited by 47
Interaction of EGFR with the tumour microenvironment: Implications for radiation treatment
Nijkamp, M. M., Span, P. N., Bussink, J., & Kaanders, J. H. A. M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.006 · Cited by 47
“Hypoxia can down regulate E-cadherin and upregulate mesenchymal markers, indicating that hypoxia can contribute to metastases-formation through the induction of EMT [72].”
BackgroundHuang, W., Jeng, Y., Lai, H., Fong, I.-U., Sheu, F.-Y. B., Lai, P., & Yuan, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119181 · Cited by 43
Molecular alterations that drive breast cancer metastasis to bone
Ottewell, P. D., O’Donnell, L., & Holen, I. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.10 · Cited by 43
Prognostic role of T wist or S nail in various carcinomas: a systematic review and meta‐analysis
Zhang, P., Hu, P., Shen, H., Yu, J., Liu, Q., & Du, J. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12343 · Cited by 45
Yamamoto, S., Huang, D., Du, L., Korn, R. L., Jamshidi, N., Burnette, B., & Kuo, M. (2016) · Radiology · doi:10.1148/radiol.2016160259 · Cited by 46
Du, L., Yamamoto, S., Burnette, B., Huang, D., Gao, K., Jamshidi, N., & Kuo, M. (2016) · Cancer Medicine · doi:10.1002/cam4.719 · Cited by 45
Loiselle, J. J., Roy, J. G., & Sutherland, L. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180258 · Cited by 43
Lee, M., Ko, H. Y., & Yun, M. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.10.1143 · Cited by 43
CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential
Li, J., Alvero, A. B., Nuti, S. V., Tedja, R., Roberts, C. M., Pitruzzello, M. C., Li, Y., Xiao, Q., Zhang, S., Gan, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1269-5 · Cited by 43
Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells
Dawson, J. C., Timpson, P., Kalna, G., & Machesky, L. M. (2012) · Oncogene · doi:10.1038/onc.2011.376 · Cited by 42
Kheshtchin, N., & Hadjati, J. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30643 · Cited by 44
“…through direct binding to HREs in the related promoters has been shown in several human cancers and mouse models (Deng et al., 2018; Evans et al., 2007; Joseph et al., 2015; Luo et al., 2011; Storci et al., 2010; Yang et al., 2008; L. Zhang et al., 2013; W. Zhang et al., 2015; Zhu et al., 2018).”
BackgroundThe regulatory mechanisms of oncomiRs in cancer
Otmani, K., Rouas, R., Berehab, M., & Lewalle, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116165 · Cited by 46
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
Yang, X., Liang, X., Zheng, M. H., & Tang, Y. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00505 · Cited by 46
Jun, Y. K., Kwon, S. H., Yoon, H. T., Park, H., Soh, H., Lee, H. J., Im, J. P., Kim, J. S., Kim, J. W., & Koh, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-76880-y · Cited by 42
Børretzen, A., Gravdal, K., Haukaas, S. A., Mannelqvist, M., Beisland, C., Akslen, L. A., & HALVORSEN, O. J. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.202 · Cited by 45
“and thereby induce EMT [4], and hypoxia is known to induce EMT by upregulation of factors such as hypoxia-inducible factor-1 alpha (Hif-1α) [1,5].”
BackgroundLysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma
Shih, Y., Chang, K., Chen, M. Y., Yu, C., Lin, D., Hsia, S., Huang, H., & Shieh, T. (2012) · Head & Neck · doi:10.1002/hed.22959 · Cited by 42
Dong, W., Kong, M., Zhu, Y., Shao, Y., Wu, D., Lu, J. L., Guo, J., & Xu, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00340 · Cited by 44
“BRG1 expression constructs (Li N. et al., 2018a) and TWIST promoter-luciferase constructs (Yang et al., 2008) have been previously described.”
BackgroundIdentification, functional insights and therapeutic targeting of EMT tumour states
Dong, A., & Blanpain, C. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00873-0 · Cited by 62
The emerging role of Twist proteins in hematopoietic cells and hematological malignancies
Mérindol, N., Riquet, A., Szablewski, V., Eliaou, J.-F., Puisieux, A., & Bonnefoy, N. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.22 · Cited by 45
Shin, S., Im, H.-J., Kwon, Y., Ye, D.-J., Baek, H., Kim, D., Choi, H., & Chun, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18645 · Cited by 41
“Previous study showed that direct binding of HIF-1α to HRE site located -83 to -79 upstream of the transcription start site of TWIST1 gene upregulates Twist1 expression in various cancer cells [53].”
BackgroundDeciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis
Gravel, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00075 · Cited by 44
The FZD 7‐ TWIST 1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma
Tan, M., Mohammad, A., Heong, V. Y. M., Wong, M. K., Tan, T. Z., Ye, J., Kuay, K. T., Thiery, J. P., Scott, C. L., & Huang, R. Y. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12425 · Cited by 44
“…is regulated by epigenetic modifications downstream to FZD7 The complex regulation of TWIST1 transcription has been reported to be regulated by STAT3 (Cheng et al., 2008; Lo et al., 2007), HIF1a (Yang et al., 2008), and NF-jB (Sosic et al., 2003) through direct binding at the TWIST1 promoter (Fig.”
Background“Reinforcement” by Tumor Microenvironment: The Seventh “R” of Radiobiology
Taghizadeh‐Hesary, F. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.09.027 · Cited by 49
Yao, W., Peng, Y., Wu, M., Zhang, W., Zhang, M., Xie, R., Zhang, P., Bai, Y., Zhao, J., Li, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9457 · Cited by 40
Self-citationLong non‐coding RNA LINC00261 inhibits cell growth and migration in endometriosis
Sha, L., Huang, L., Luo, X., Bao, J., Gao, L., Pan, Q., Guo, M., Zheng, F., & Wang, H. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13427 · Cited by 40
Kim, S., Park, Y. R., Lee, S. T., & Kim, S. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4166 · Cited by 41
The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis
Peng, P., Hsu, K., Lai, J. C., & Wu, K. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.03.005 · Cited by 43
Self-citationChang, L., Chen, C., Huang, D., Pai, H., Pan, S., & Teng, C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22428 · Cited by 45
Embryonic Protein Nodal Promotes Breast Cancer Vascularization
Quail, D. F., Walsh, L. A., Zhang, G., Findlay, S. D., Moreno, J. C. A., Fung, L. A., Ablack, A. L., Lewis, J. D., Done, S. J., Hess, D. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3951 · Cited by 42
Metabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 43
Zhao, X. G., Ni, S., Song, Y., & Hu, K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.048 · Cited by 40
MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b
Tsukerman, P., Yamin, R., Seidel, E., Khawaled, S., Schmiedel, D., Bar-Mag, T., & Mandelboim, O. (2014) · Oncotarget · doi:10.18632/oncotarget.2559 · Cited by 40
Chiou, S., Chen, S., Chang, Y.-L., Chen, Y., Li, H.-Y., Chen, D.-T., Wang, H., Chang, C., Chen, Y., & Ku, H. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01034.x · Cited by 39
Self-citationYoo, Y., Christensen, J., Gu, J., & Huang, E. L. (2011) · Science Signaling · doi:10.1126/scisignal.2002072 · Cited by 41
Cui, H., Grosso, S., Schelter, F., Mari, B. P., & Krüger, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00134 · Cited by 44
“HIF-1 promotes metastasis by initiating epithelialto-mesenchymal transition by the induction of the transcription factors Snail (Mak et al., 2010) and Twist (Yang et al., 2008), which in turn lead to a repression of E-Cadherin.”
BackgroundAlidadiani, N., Ghaderi, S., Dilaver, N., Bakhshamin, S., & Bayat, M. (2018) · Gene · doi:10.1016/j.gene.2018.06.049 · Cited by 39
Liu, M., Liang, Y., Zhu, Z., Wang, J., Cheng, X., Cheng, J., Xu, B., Li, R., Liu, X., & Wang, Y. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01313 · Cited by 39
Wan, Y., Liu, H., Zhang, M., Huang, Z., Zhou, H., Zhu, Y., Tao, Y., Xie, N., Liu, X., Hou, J., et al. (2020) · Head & Neck · doi:10.1002/hed.26104 · Cited by 39
“The HRs and 95% CIs were directly provided in 11 studies,(10,27,31,32,36,39,41,43-45) and were estimated based on the Kaplan-Meier survival curves in the other 11 studies.(26,28-30,33-35,37,38,40,42) As shown in Table S1, the quality scores ranged from 5 to 11, indicating an overall moderate study quality.”
BackgroundMethodResultLiang, X., Zeng, J., Wang, L., Li, S., Ma, X., Li, S., Wu, Y., Ma, L., Ci, X., Guo, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3756 · Cited by 42
“Other signaling pathways and many important transcriptional factors are involved in EMT [9, 10].”
BackgroundDevelopment and Maintenance of Cancer Stem Cells under Chronic Inflammation
Tanno, T., & Matsui, W. H. (2011) · Journal of Nippon Medical School · doi:10.1272/jnms.78.138 · Cited by 47
Twist may be associated with invasion and metastasis of hypoxic NSCLC cells
Wei, L., Sun, J., Cui, Y., Jiang, S.-L., Wang, X.-W., Lv, L., Xie, L., & Song, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-4896-2 · Cited by 39
“Twist and HIF-1α protein were expressed mainly in the nucleus of tumor cells (Fig.”
BackgroundResultInfluentialNie, C., Lv, H., Bie, L., Hou, H., & Chen, X. (2018) · Medicine · doi:10.1097/md.0000000000013551 · Cited by 39
Suri, G. S., Kaur, G., Carbone, G. M., & Shinde, D. A. (2023) · Cancer Reports · doi:10.1002/cnr2.1795 · Cited by 57
Nakamura, T., Yamashita, K., Sato, T., Ema, A., Naito, M., & Watanabe, M. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.03.007 · Cited by 40
Dey, P., Velázquez‐Villegas, L. A., Faria, M., Turner, A. P. F., Jonsson, P., Webb, P., Williams, C., Gustafsson, J.-Å., & Ström, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128239 · Cited by 43
Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung cancers
Kohnoh, T., Hashimoto, N., Ando, A., Sakamoto, K., Miyazaki, S., Aoyama, D., Kusunose, M., Kimura, M., Omote, N., Imaizumi, K., et al. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0308-3 · Cited by 39
The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells
Alférez, D., Simões, B. M., Howell, S. J., & Clarke, R. B. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0114-z · Cited by 44
Yang, H., Lin, P.-Y., Vadivalagan, C., Lin, Y., Lin, K., & Hseu, Y. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03456-w · Cited by 41
Unraveling the Role of FOXQ1 in Colorectal Cancer Metastasis
Abba, M. L., Patil, N., Rasheed, S. A. K., Nelson, L. D., Mudduluru, G., Leupold, J. H., & Allgayer, H. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0024 · Cited by 38
HIF-2α not HIF-1α overexpression confers poor prognosis in non–small cell lung cancer
Gao, Z.-J., Wang, Y., Yuan, W.-D., Yuan, J.-Q., & Yuan, K. (2017) · Tumor Biology · doi:10.1177/1010428317709637 · Cited by 36
Hypoxia-induced upregulation of Orai1 drives colon cancer invasiveness and angiogenesis
Liu, X., Wan, X., Kan, H., Wang, Y., Yu, F., Feng, L., Jin, J., Zhang, P., & Ma, X. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.008 · Cited by 35
Kozal, K., & Krześlak, A. (2022) · Cancers · doi:10.3390/cancers14184518 · Cited by 39
Hu, Y., Zhao, Y., Li, P., Lu, H., Li, H., & Ge, J. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.07.032 · Cited by 42
Thenuwara, G., Javed, B., Singh, B., & Tian, F. (2024) · Sensors · doi:10.3390/s24092865 · Cited by 43
Shieh, T., Chang, K., Tu, H., Shih, Y.-H., Ko, S.-Y., Chen, Y.-C., & Liu, C. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.04.009 · Cited by 38
Self-citationChen, Y., Lan, H., Wu, Y., Yang, W., Chiou, A. E. T., & Yang, M. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13656 · Cited by 38
“We previously reported that Twist1 cooperates with BMI1 to suppress the expression of microRNA let-7i, resulting in the activation of Rac1 and inducing mesenchymal movement in 3D environment.(31) In this study, we observed that, in 3D culture environment, Rac1 activation of mesenchymal-like HNSCC cells (SAS & OECM-1)…”
BackgroundSelf-citationJo, H., Lee, J., Jeon, J. Y., Kim, S. Y., Chung, J.-I., Ko, H. Y., Lee, M., & Yun, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58124-1 · Cited by 39
Epithelial–Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review
González‐González, R., Sarabia, G. O., Molina‐Frechero, N., Salas-Pacheco, J. M., Salas-Pacheco, S. M., Lavalle‐Carrasco, J., Verdín, S. L., Tremillo-Maldonado, O., & Bologna‐Molina, R. E. (2021) · Cancers · doi:10.3390/cancers13123027 · Cited by 42
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 39
Mechanisms of tumor promotion by reactive oxygen species
Kobliakov, V. A. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910060015 · Cited by 39
Humtsoe, J. O., Koya, E., Pham, E., Aramoto, T., Zuo, J., Ishikawa, T., & Kramer, R. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.11.011 · Cited by 36
Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression
Sulaiman, A., Zemin, Y., & Wang, L. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160124 · Cited by 41
“TWIST is notably activated through hypoxia-inducible factor 1α under intratumoral hypoxic conditions([49]), a trait associated with chemotherapy resistance([50]).”
BackgroundKim, I., Lee, J. H., Kim, S., Hwang, H., Kim, T., & Cho, E. (2018) · Cancer Science · doi:10.1111/cas.13791 · Cited by 37
“Transcription factors regulated by HIF‐1α, such as Zeb, Twist and Snail1, drive pathological EMT and thus promote malignant tumor progression and metastasis.(31,32) We have found that hypoxia (1% or 0.”
BackgroundEpigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
Čierniková, S., Earl, J., García‐Bermejo, L., Števurková, V., Carrato, A., & Smolková, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114091 · Cited by 41
Significance of Heterogeneous Twist2 Expression in Human Breast Cancers
Mao, Y., Zhang, N., Xu, J., Ding, Z., Zong, R., & Liu, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048178 · Cited by 37
Xu, Y., Xu, Y., Liao, L., Zhou, N., Theissen, S. M., Liao, X.-H., Nguyen, H., Ludwig, T., Qin, L., Martinez, J. D., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.06.021 · Cited by 36
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion
Nodale, C., Sheffer, M., Jacob‐Hirsch, J., Folgiero, V., Falcioni, R., Aiello, A., Garufi, A., Rechavi, G., Givol, D., & D’Orazi, G. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.4.18694 · Cited by 36
“g, vimentin) leading to invasive phenotype.(28) We have found that HIPK2, but not the K221R kinase-deficient Figure 2.”
BackgroundUncovering the role of hypoxia inducible factor-1α in skin carcinogenesis
Nys, K., Maes, H., Dudek, A. M., & Agostinis, P. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.02.001 · Cited by 40
Feng, Z., Gan, H., Cai, Z., Li, N., Yang, Z., Lu, G., & Chen, J. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys237 · Cited by 41
Xi, Y., Wei, Y., Sennino, B., Ulsamer, A., Kwan, I., Brumwell, A. N., Tan, K., Aghi, M. K., McDonald, D. M., Jablons, D. M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.530 · Cited by 32
Xie, J., Gao, H. Y., Peng, J., Han, Y., Chen, X., Jiang, Q., & Wang, C. (2015) · PubMed · Cited by 39
RetractedThe role of epithelial-mesenchymal transition in pancreatic cancer.
Pan, J., & Yang, M. (2011) · PubMed · doi:10.3978/j.issn.2078-6891.2011.022 · Cited by 42
Self-citationHypoxia signaling and metastatic progression
Schito, L., & Rey-Keim, S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.001 · Cited by 37
The role of steroid hormones in breast cancer stem cells
Simões, B. M., Alférez, D., Howell, S. J., & Clarke, R. B. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0350 · Cited by 39
“This epithelial–mesenchymal transition or vice-versa (mesench- ymal–epithelial transition) is believed to be determined by the tumor microenvironment, with factors like hypoxia or transforming growth factor beta playing a key role in this process (Thiery 2002, Yang et al. 2008).”
BackgroundZhang, G., Yu, F., Li, Y., Qin, W. D., Song, S., Zhou, F., & Tong, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006680 · Cited by 36
VBP 1 represses cancer metastasis by enhancing HIF ‐1α degradation induced by pVHL
Kim, J. A., Choi, D. K., Min, J. S., Kang, I., Kim, J. C., Kim, S., & Ahn, J. K. (2017) · FEBS Journal · doi:10.1111/febs.14322 · Cited by 39
Dobrian, A. D. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00108 · Cited by 39
Zhao, B., Liu, L., Mao, J., Zhang, Z., Wang, Q., & Li, Q. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03387-3 · Cited by 36
Glioblastoma Circulating Cells: Reality, Trap or Illusion?
Lombard, A., Goffart, N., & Rogister, B. (2015) · Stem Cells International · doi:10.1155/2015/182985 · Cited by 40
Bendinelli, P., Maroni, P., Matteucci, E., & Desiderio, M. A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0389-y · Cited by 35
RetractedMetastasis inhibition in breast cancer by targeting cancer cell extravasation
Cominetti, M. R., Altei, W. F., & Selistre-de-Araújo, H. S. (2019) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s166725 · Cited by 38
“These transcription factors include the SNAIL family zinc fi nger transcription factors (SNAIL1 and SNAIL2), 38,39 the TWIST family basic helix-loop-helix transcription factors (TWIST1 and TWIST2), 35,40 – 42 and the zinc fi nger E-box binding homeobox proteins (ZEB1 and ZEB2).”
Metadata
- Authors
- Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J.
- Affiliations
- National Yang Ming University (TW)
- Taipei Veterans General Hospital (TW)
- Mackay Memorial Hospital (TW)
- National Taiwan University (TW)
- Corresponding author
- Wu, Kou-Juey
- Venue
- Nature Cell Biology
- Published
- 2008-02-24
- Volume
- 10
- Issue
- 3
- Pages
- 295-305
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2134361367
- Cited by
- 1,345
- References
- 41
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 62 · 2023: 63 · 2022: 73 · 2021: 104 · 2020: 74 · 2019: 66 · 2018: 82 · 2017: 80 · 2016: 96 · 2015: 82 · 2014: 89 · 2013: 94 · 2012: 76
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- HIF-1α, Twist, metastasis, epithelial-mesenchymal transition, hypoxia response element, transcriptional regulation, snails, head and neck cancer, tumor progression
- MeSH terms
- Snail Family Transcription Factors, Cell Communication, Cell Differentiation, Humans, Neoplasm Metastasis, Neoplasms, Nuclear Proteins, Phenotype, Prognosis, Transcription Factors, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit, Twist-Related Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.